| Database ID | Agent | Target | Cancer Type | Detail |
| DB00571 | cixutumumab | Insulinlike growth factor I receptor | soft tissue sarcomas | view |
| DB00572 | R1507 | Insulinlike growth factor I receptor | soft tissue sarcomas | view |
| DB00573 | figitumumab | Insulinlike growth factor I receptor | soft tissue sarcomas | view |
| DB00574 | sorafenib everolimus | NA | soft tissue sarcomas | view |
| DB00575 | ridaforolimus | Serine/threonineprotein kinase mTOR | soft tissue sarcomas | view |
| DB00576 | regorafenib | Protooncogene tyrosineprotein kinase receptor ret
Mast/stem cell growth factor receptor
Vascular endothelial growth factor receptor 2
Vascular endothelial growth factor receptor 3 | advanced solid tumors | view |
| DB00577 | imatinib mesylate | Abl
Plateletderived growth factor receptor
Mast/stem cell growth factor receptor | soft tissue sarcomas | view |
| DB00578 | cediranib | Vascular endothelial growth factor receptor 2 | advanced solid tumors | view |
| DB00579 | imatinib mesylate | Abl
Plateletderived growth factor receptor
Mast/stem cell growth factor receptor | soft tissue sarcomas | view |
| DB00580 | imatinib mesylate | Abl
Plateletderived growth factor receptor
Mast/stem cell growth factor receptor | advanced solid tumors | view |
| DB00581 | alisertib | aurora kinase A | advanced solid tumors | view |
| DB00582 | alisertib | aurora kinase A | advanced solid tumors | view |
| DB00583 | alisertib | aurora kinase A | advanced solid tumors | view |
| DB00584 | alisertib | NA | advanced solid tumors | view |
| DB00585 | sorafenib | Vascular endothelial growth factor receptor 1
BRaf protooncogene serine/threonineprotein kinase
Protooncogene tyrosineprotein kinase receptor ret | soft tissue sarcomas | view |